HF-ACTION Risk Calculator

Clinical calculation support · Verify results before clinical use

Primary Endpoint Risk Score

Enter baseline CPX duration, KCCQ symptom stability, serum BUN, and sex to calculate the published simplified score.

HFACTION

Use exercise duration recorded during the baseline cardiopulmonary exercise test (CPX), not the 6-minute walk test.

KCCQ symptom stability compared with 2 weeks ago

Select the response corresponding to change in heart-failure symptoms.

Enter BUN in mg/dL. Do not enter urea in mmol/L without converting units first.

Sex
Reset Form

About the HF-ACTION score

The HF-ACTION predictive score was developed in 2,331 ambulatory patients with chronic systolic heart failure (NYHA class II–IV and LVEF ≤35%) followed for a median of 2.5 years. The primary endpoint was all-cause death or all-cause hospitalization.

This calculator implements the paper's simplified point score for the primary composite endpoint. It does not implement the separate all-cause mortality score.

Score components

VariablePublished points
CPX duration65 − (2.2 × duration in minutes)
KCCQ: worse15
KCCQ: no change/no symptoms0
KCCQ: better8
BUN 0–19 / 20–39 / 40–59 / 60–79 / ≥80 mg/dL0 / 3 / 7 / 10 / 14
Male sex6

Expected 1-year event risk by score interval

ScoreDecileExpected risk
0–38121.4%
39–43228.5%
44–47332.7%
48–49435.9%
50–52539.1%
53–55642.3%
56–58746.1%
59–62850.5%
63–67956.4%
68–1001068.0%

References

O’Connor CM, Whellan DJ, Wojdyla D, et al. Factors related to morbidity and mortality in patients with chronic heart failure with systolic dysfunction: the HF-ACTION predictive risk score model. Circ Heart Fail. 2012;5(1):63–71. doi:10.1161/CIRCHEARTFAILURE.111.963462. PMID: 22114101.
ClinicalTrials.gov. HF-ACTION, NCT00047437. Trial record.

Clinical use and limitations

  • Derived from ambulatory patients with HFrEF and NYHA class II–IV; do not assume validity in acute decompensated HF or HFpEF.
  • The score's risk estimates reflect the original study cohort and are not a substitute for contemporary clinical assessment.
  • External validation in an independent cohort was not reported in the original publication.
Clinical disclaimer: This tool supports risk stratification and must not be used as the sole basis for clinical decisions. Confirm the input units and clinical context. Risk estimates are derived from the original HF-ACTION cohort and may not be calibrated to current local populations or treatment patterns.